stoxline Quote Chart Rank Option Currency Glossary
ZyVersa Therapeutics, Inc. (ZVSA)
0.899  -0.251 (-21.83%)    12-08 16:00
Open: 1.15
High: 1.15
Volume: 919,406
Pre. Close: 1.15
Low: 0.8921
Market Cap: 1(M)
Technical analysis
2023-12-08 4:47:09 PM
Short term     
Mid term     
Targets 6-month :  2.21 1-year :  3.53
Resists First :  1.89 Second :  3.02
Pivot price 0.47
Supports First :  0.05 Second :  0.04
MAs MA(5) :  1.28 MA(20) :  0.38
MA(100) :  0.18 MA(250) :  1.04
MACD MACD :  0.2 Signal :  0.1
%K %D K(14,3) :  45.1 D(3) :  55.3
RSI RSI(14): 57.9
52-week High :  25 Low :  0.05
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ZVSA ] has closed below upper band by 35.7%. Bollinger Bands are 1747.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.15 - 1.16 1.16 - 1.16
Low: 0.88 - 0.89 0.89 - 0.89
Close: 0.89 - 0.9 0.9 - 0.91
Company Description

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.

Headline News

Thu, 07 Dec 2023
Healthcare Stocks on the Move Thursday: SLDB, UPC, SYRS, FBIO, ZVSA, WVE, OMER, SERA - InvestorsObserver

Thu, 07 Dec 2023
ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate ... - Yahoo Finance

Thu, 07 Dec 2023
Why ZyVersa Therapeutics Shares Are Down 40% - ZyVersa Therapeutics (NASDAQ:ZVSA) - Benzinga

Thu, 07 Dec 2023
Why Is ZyVersa Therapeutics (ZVSA) Stock Down 44% Today? - InvestorPlace

Thu, 07 Dec 2023
ZyVersa Therapeutics stock dips on pricing $5.0 million securities offering - Seeking Alpha

Wed, 06 Dec 2023
ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 0 (M)
Shares Float 44 (M)
Held by Insiders 3.895e+007 (%)
Held by Institutions 54.4 (%)
Shares Short 2,500 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.567e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -55.7 %
Return on Equity (ttm) -2 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.55
Qtrly Earnings Growth -2.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -10 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 2.3e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android